Nat Simons Charles River Laboratories International, Inc. Transaction History
Meritage Group LP
- $3.52 Billion
- Q2 2024
A detailed history of Nat Simons (Meritage Group LP) transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Meritage Group LP holds 1,182,657 shares of CRL stock, worth $224 Million. This represents 6.95% of its overall portfolio holdings.
Number of Shares
1,182,657
Previous 1,182,268
0.03%
Holding current value
$224 Million
Previous $320 Million
23.73%
% of portfolio
6.95%
Previous 7.54%
Shares
4 transactions
Others Institutions Holding CRL
# of Institutions
731Shares Held
51.8MCall Options Held
233KPut Options Held
236K-
Vanguard Group Inc Valley Forge, PA6.1MShares$1.16 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$965 Million0.02% of portfolio
-
State Street Corp Boston, MA2.09MShares$396 Million0.02% of portfolio
-
Kayne Anderson Rudnick Investment Management LLC Los Angeles, CA1.91MShares$362 Million0.99% of portfolio
-
Clearbridge Investments, LLC New York, NY1.37MShares$259 Million0.24% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $9.64B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...